Stock Valuation / GEHC
Is GE HealthCare Technologies Inc. (GEHC) Overvalued? Fair Value & 5-Year Target
GE HealthCare Technologies Inc. trades at $68.79 (P/E 15.81). Our reference model estimates a fair value of $78.87 at its recent average P/E of 18.13.
| Current price | $68.79 |
|---|---|
| Current EPS | $4.35 |
| Current P/E | 15.81 |
| Average P/E | 18.13 |
| Fair value (at avg P/E) | $78.87 |
| Upside to fair value | +14.7% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $218.74 |
What drives GEHC's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatme
Frequently asked questions
What is GEHC's fair value?
At its recent average P/E of 18.13, GE HealthCare Technologies Inc. (GEHC) has a reference fair value of about $78.87, which is +14.7% versus the current price of $68.79.
Is GE HealthCare Technologies Inc. (GEHC) overvalued or undervalued?
Based on the average-P/E reference model, GE HealthCare Technologies Inc. looks undervalued relative to fair value by roughly +14.7%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for GEHC?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $218.74. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive GEHC valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.